Nursing care
Oxytocin: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Oxytocin induces or augments labour by stimulating rhythmic uterine contractions, and it is titrated to the fetal response, not just the contraction pattern. Stop the infusion for tachysystole or a non-reassuring fetal heart rate before the mother reports discomfort. Water intoxication is the toxicity to watch for with prolonged, high-dose use.
Mechanism, simply
Oxytocin binds receptors on the myometrium and causes the uterine muscle to contract rhythmically, mimicking the hormone the body releases naturally during labour. Receptor density increases as pregnancy progresses toward term, which is why the same dose can produce very different contraction strength depending on gestational age and how far labour has already progressed.
It also has a mild antidiuretic effect structurally related to vasopressin, which becomes clinically relevant only with prolonged infusions at high rates and large volumes of electrolyte-free fluid, where it can contribute to water intoxication and hyponatremia. At standard labour induction and augmentation doses this effect is rarely significant, but it is worth knowing why the drug carries the risk.
Indications you will see on the ward
The two indications you will see most often are labour induction, for reasons such as post-term pregnancy, pre-eclampsia, or ruptured membranes without spontaneous labour, and labour augmentation, when contractions have started but are too weak or infrequent to progress labour. It is also given after delivery, of the baby and the placenta, to contract the uterus and control postpartum haemorrhage.
In the postpartum indication the goal and the dose are different from the induction or augmentation setting. A firm, contracted fundus and controlled bleeding are the endpoints, rather than a specific contraction frequency, and the infusion is typically not titrated against a fetal heart rate because the baby has already been delivered.
Assessment before administration
Confirm fetal presentation, gestational age and an established baseline fetal heart rate pattern on continuous electronic monitoring before starting the infusion. Review the indication for induction or augmentation and confirm there is no contraindication such as placenta previa, vasa previa, active genital herpes, or a prior classical caesarean scar.
Assess the current contraction pattern, cervical status if a vaginal exam has been done, and maternal vital signs as a baseline. Confirm the infusion is running on a dedicated pump line piggybacked into a main IV line, so it can be stopped immediately and independently of any fluids or other medications the mother is receiving.
Toxicity and the antidote
There is no specific pharmacological antidote for oxytocin. Stopping the infusion is the intervention, and because of its short half-life, uterine activity typically begins to settle within minutes of discontinuation. Stop the infusion for tachysystole, generally defined as more than five contractions in ten minutes averaged over thirty minutes, or for a non-reassuring fetal heart rate pattern such as late decelerations, prolonged deceleration, minimal or absent variability, or bradycardia. The drug is titrated to how the fetus is tolerating labour, not to the contraction pattern alone, so a fetal heart rate change is reason enough to stop even if the contraction pattern looks acceptable.
With the infusion stopped, reposition the mother onto her left side, increase the primary IV fluid rate, and administer oxygen if the fetal heart rate does not recover promptly. Notify the provider and prepare for tocolytic administration such as terbutaline if uterine activity does not settle. Water intoxication from prolonged high-dose use presents as headache, confusion, and seizures from hyponatremia, and is managed by stopping the infusion and restricting free water.
Interactions that matter
Concurrent use with other uterotonics, or with prostaglandins used for cervical ripening such as misoprostol or dinoprostone, increases the risk of tachysystole and uterine rupture, so confirm timing between agents against your facility's protocol before starting oxytocin. Epidural anaesthesia and other vasodilating agents can compound maternal hypotension when combined with oxytocin's own mild hypotensive effect after rapid IV administration, so blood pressure should be checked more frequently around the time either is started or adjusted.
Large volumes of electrolyte-free IV fluids given alongside high-dose or prolonged oxytocin infusions raise the risk of water intoxication because of the drug's antidiuretic effect. This is mainly a concern with high-dose regimens used for postpartum haemorrhage control rather than standard induction rates, but total fluid intake should still be tracked.
What the patient must be told
Explain that oxytocin will bring on contractions that may feel stronger and closer together than early spontaneous labour, and that this is expected and monitored closely rather than a sign of a problem. Tell the mother that continuous fetal monitoring is in place specifically so the team can adjust or stop the infusion the moment the baby shows any sign of not tolerating labour, and that this can happen even without her feeling anything different.
Encourage her to report contractions that feel constant with little or no break between them, since this is one of the signs the team is watching for and her report can prompt an earlier check. If oxytocin is being given after delivery, explain that it is to help the uterus contract and control bleeding, and that cramping in the lower abdomen is expected during this phase.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our maternity and newborn practice questions are the closest set to what this page covers.
Common questions
When should oxytocin be stopped during labour induction?
Stop it for tachysystole, more than five contractions in ten minutes averaged over thirty minutes, or for a non-reassuring fetal heart rate pattern such as late decelerations or minimal variability. The infusion is titrated to fetal tolerance, not to the contraction pattern alone.
What is the antidote for oxytocin toxicity?
There is no specific antidote. Stopping the infusion is the intervention, and because oxytocin has a short half-life, uterine activity usually settles within minutes.
Can oxytocin cause water intoxication?
Yes, with prolonged high-dose infusions and large volumes of electrolyte-free IV fluid, due to its mild antidiuretic effect. It presents as headache, confusion and seizures from hyponatremia, and is managed by stopping the infusion and restricting free water.
Is oxytocin given after delivery as well as before?
Yes. After delivery of the baby and placenta it is given to contract the uterus and control postpartum bleeding, with a firm fundus as the goal rather than a specific contraction frequency.
What should be assessed before starting an oxytocin infusion?
A baseline fetal heart rate pattern on continuous monitoring, current contraction pattern, gestational age, and confirmation there is no contraindication such as placenta previa or a prior classical caesarean scar.